Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan

Thomas E. Witzig, Arturo Molina, Leo I. Gordon, Christos Emmanouilides, Russell J. Schilder, Ian W. Flinn, Mohamed Darif, Roger Macklis, Katie Vo, Gregory A. Wiseman

Research output: Contribution to journal › Article › peer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan'. Together they form a unique fingerprint.

Medicine & Life Sciences